Cleopatra Hospitals Group S.A.E. (EGX:CLHO)
Egypt · Delayed Price · Currency is EGP 15.89
-0.26 (-1.61%)
At close: Jun 4, 2026
EGX:CLHO Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, EGX:CLHO stock has a consensus rating of "Buy" and an average price target of E£14.57. The average 1-year stock price forecast is 8.31% lower than the current stock price, while the lowest is E£12.70 (-20.08%) and the highest is E£17.50 (+10.13%).
Price Target: E£14.57 (-8.31%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for EGX:CLHO stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Oct '25 | Dec '25 | Feb '26 | Mar '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 2 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 3 | 4 | 4 | 3 | 3 |
Financial Forecast
Revenue This Year
10.06B
from 7.23B
Increased by 39.19%
Revenue Next Year
12.23B
from 10.06B
Increased by 21.58%
EPS This Year
0.59
from 0.57
Increased by 3.79%
EPS Next Year
0.79
from 0.59
Increased by 32.74%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EGP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.1B | ||
| Avg | 10.1B | ||
| Low | 10.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 39.2% | ||
| Avg | 39.2% | ||
| Low | 39.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.59 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 3.8% | ||
| Low | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.